AssetPro
Insights on High-Potential Assets
Assess and benchmark early-stage molecules with near-real-time insights from an AI-based platform that tracks internal and external innovation through multiple data sources from the life sciences domain. Prioritize acquisition targets and internal asset investments based on expert analysis and the latest scientific research. Proactively identify opportunities and determine asset attractiveness aligned with your portfolio expansion plan.